| Thanks to SoCalBio Weekly Update Sponsor |
Coming in October
| CSUPERB Life Sciences Workforce Summit
October 12, 10am-4pm California State University Los Angeles
Free Admission
In partnership with SoCalBio, the Los Angeles City Workforce Investment Board and the California Community Colleges, the California State University Program for Education and Research in Biotechnology (CSUPERB) will be holding a one day summit to share best practices in private/public partnerships for life-science workforce development. Register Now or contact the CSUPERB Program Office at (619) 594-2822 to learn more. |
Coming in 2011
|  | Exploring opportunities and challenges of cloud computing in the highly regulated biotech and medical device industries.
|
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
When you join, you will enjoy significant discounts on products and services from lab and office supplies to insurance and scientific publications. Discounts are exclusive to SoCalBio member companies in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino counties... Click here to see why |  |
|
| Speaker Added
| SoCalBio Investor & Partnership Conference Morning Keynote to be Delivered by Internationally Recognized Authority on Global, Economic, Political and Social Trends, Joel Kotkin
Mr. Kotkin will talk about strategies to maintain and increase California's economic and technological competitiveness in a rapidly changing world economy. Described by the New York Times as America's "uber-geographer," for over three decades Mr. Kotkin has been one of the nation's most prolific and widely-published journalists. He is a highly respected speaker and futurist, he consults for many leading economic development organizations, private companies, regions and cities. Most recently, he wrote "THE NEXT HUNDRED MILLION: America in 2050," a book published in February 2010 by The Penguin Press. The book explores how the nation will evolve in the next four decades. It has received rave reviews from The New York Times, Wall Street Journal, the Globe and Mail, and National Public Radio... Click here to read more about Mr. Kotkin |
 | |
| Register Now for These Business Mixers | SoCalBio Networking Forum in Orange County
Telehealth:
If everybody says it is good for you, why progress is slowOctober 14, 4:00 to 7:00 PM
UCI University Club
Telehealth, as other information and communication technologies introduced to support the delivery of health care services, is considered as a means to answer many of the imperatives currently challenging health care systems. However, telehealth utilization remains limited in many settings, despite increased availability of technology and telecommunication infrastructure . What are the obstacles and how can we speed its implementation of telehealth? ... Register now
SoCalBio/JETRO Seminar in Orange County
Doing Business With Japan
Opportunities for medical device companies
October 26, 8:30 AM - 11:00 AM
UCI University Club
Free Admission
Organized in collaboration with JETRO, this seminar will enable you to learn how to navigate the Japanese regulatory pathways, collaborate with Japanese companies, and understand future medical device needs and trends of Japan. ... Register now
|
|  |
| Opinion | Reduced VC Funds Means New Challenges for Medtech Start-Ups
 A reduced pool of venture capital presents some new challenges for medical device start-ups, which must now rethink strategies for attracting funding. Experts say VC dollars are still available, but the amount of dollars and the timing for exits have changed. Old routes for seeking funding are no longer viable .. Read more |
| Recommended Reading | Medical Technology Innovation in a Time of Upheaval
The impact of recent economic, policy, and regulatory shifts
by Sharad Rastogi, PRTM
Conducted in March and April, MedTech Innovation in an Era of Change is a survey that PRTM conducted, It focuses on Medtech executives' opinions on recent economic downturn, expanded health care insurance coverage, payment reform, device industry tax, comparative effectiveness research, physician payment sunshine provision, risk management scrutiny, 510(k) reform, and the National Medical Device Registry .. Click here to acess survey results |
From the Lab Bench
| Childrens Hospital Los Angeles Discovers a New Method to Overcome Radiation Resistance in Leukemia
 B-lineage acute lymphoblastic leukemia (ALL) is the most common cancer occurring in children and adolescents. Despite having received intensive chemotherapy, some patients have recurring disease, known as relapse. For these individuals, the prospect of long-term survival is poor. A team of researchers lead by Fatih M. Uckun, MD, of The Saban Research Institute of Childrens Hospital Los Angeles has determined that radiation resistance in leukemia can be overcome by selectively attacking a molecular target known as SYK tyrosine kinase... Read more
|
Biosimilars
| FDA Wants More Info on Teva Version of Amgen Drug
The FDA is seeking more data, but will not require any additional clinical trials. Teva, which is the largest manufacturer of generic drugs, is seeking approval of its drug Neutroval, which is a copy of Neupogen, which treats neutropenia, the a lack of white blood cells in patients being treated for cancer... Read more
|
Studies
| Amgen Drug May Block Some Breast Cancer, Studies Hint
Mice with breast cancer fueled by the hormone progesterone had their tumors shrink when a protein called RANK ligand was blocked, according to a study by Amgen researchers published in the journal Nature. RANK ligand plays a key role in bone regeneration and is the target of denosumab, a drug that Amgen has made the focus of the biggest development program in its history... Read more Transcatheter Aortic-Valve Implantation (TAVI) Reduces Mortality Rate Compared to Standard Therapy
 The New England Journal of Medicine reported this month that, for patients with severe aortic stenosis who are not candidates for surgery, Transcatheter Aortic-Valve Implantation (TAVI) using the Edwards SAPIEN valve significantly reduced mortality compared to standard treatment. At one year, the rate of death from any cause was 30% with TAVI vs. 50.7% with standard treatment. However, this method had a higher incidence of strokes and major vascular complications compared to standard treatment ... Read more
|
Jobs Available
| - Agensys, a Subsidiary of Astellas Pharma (Santa Monica):
- House Ear Institute (Los Angeles):
- Advanced Bionics (Sylmar and Valencia):
- LoneStar Heart (Laguna Hills):
|
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
